Daniel Bowen
Obstetrics & Gynecology · Cincinnati, OHNPI 1366548638
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $613 and has fallen 51.9% since, to $295 in 2025.
Across 128 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$406
- Therapeuticsmd, Inc.$242
- Mayne Pharma Commercial LLC$199
- Sumitomo Pharma America, Inc.$198
- Aspira Women's Health Inc$176
- Astellas Pharma US Inc$169
- plus $841 from 16 others
What the payments were for
- Food & beverage$2,18998%
- Education$432%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $406 |
| Therapeuticsmd, Inc. | 18 | $242 |
| Mayne Pharma Commercial LLC | 8 | $199 |
| Sumitomo Pharma America, Inc. | 14 | $198 |
| Aspira Women's Health Inc | 3 | $176 |
| Astellas Pharma US Inc | 8 | $169 |
| Minerva Surgical, Inc | 6 | $167 |
| Hologic Sales And Service, LLC | 8 | $161 |
| Shield Therapeutics Inc | 7 | $111 |
| Channel Medsystems, Inc. | 1 | $60 |
| Pfizer | 4 | $56 |
| Lupin Inc. | 3 | $43 |
| Novo Nordisk | 2 | $39 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $38 |
| Exeltis, USA Inc. | 2 | $33 |
| Sage Therapeutics, LLC | 1 | $24 |
| AMAG Pharmaceuticals, Inc. | 2 | $23 |
| Evofem Biosciences, Inc. | 1 | $19 |
| Gynesonics, Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Mission Pharmacal Company | 1 | $16 |
| Roche Diagnostics Corporation | 1 | $16 |
How this compares
$2,232 in reported general payments places this provider in the 75th percentile of 1,376 obstetrics & gynecology providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 27 | $1,488 |
| Ampicillin Trihydrate | 12 | $171 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Cincinnati
- David SchwartzCincinnati$169K
- Gerard ReillyCincinnati$74K
- Michael KarramCincinnati$47K
- Sunbal JavaidCincinnati$32K
- James SosnowskiCincinnati$31K
- Gretchen FermannCincinnati$31K
- Rocco RossiCincinnati$18K
- Meredith PensakCincinnati$14K
- David DhanrajCincinnati$12K
- David SheynCincinnati$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.